BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6682201)

  • 1. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
    Granato JE; Stern BJ; Ringel A; Karim AH; Krumholz A; Coyle J; Adler S
    Ann Neurol; 1983 Jul; 14(1):89-90. PubMed ID: 6614876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroleptic malignant syndrome. A priority system.
    Neppe VM
    S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
    Khan A; Jaffe JH; Nelson WH; Morrison B
    J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
    Eles GR; Songer JE; DiPette DJ
    Arch Intern Med; 1984 Jun; 144(6):1296-7. PubMed ID: 6732389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rigidity and fever in two psychotic patients.
    Greenberg MS; Gorelick PB
    Hosp Pract (Off Ed); 1986 Jul; 21(7):171, 174. PubMed ID: 2873146
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of neuroleptic malignant syndrome with dantrolene.
    Goekoop JG; Carbaat PA
    Lancet; 1982 Jul; 2(8288):49-50. PubMed ID: 6123782
    [No Abstract]   [Full Text] [Related]  

  • 10. Questions about dantrolene for neuroleptic malignant syndrome.
    Henderson VW
    Am J Psychiatry; 1983 Jan; 140(1):137-9. PubMed ID: 6128926
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome: response to dantrolene sodium.
    May DC; Morris SW; Stewart RM; Fenton BJ; Gaffney FA
    Ann Intern Med; 1983 Feb; 98(2):183-4. PubMed ID: 6824251
    [No Abstract]   [Full Text] [Related]  

  • 12. Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.
    Bismuth C; de Rohan-Chabot P; Goulon M; Raphael JC
    Acta Neurol Scand Suppl; 1984; 100():193-8. PubMed ID: 6148831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fulminant case of neuroleptic malignant syndrome.
    Teo SK; Lam KN; Chew WL
    Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: two case reports with a literature review.
    Geller B; Greydanus DE
    J Clin Psychiatry; 1979 Feb; 40(2):102-3. PubMed ID: 762029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome.
    Lancet; 1984 Mar; 1(8376):545-6. PubMed ID: 6142258
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating neuroleptic malignant syndrome.
    Lazarus A
    Am J Psychiatry; 1984 Aug; 141(8):1014-5. PubMed ID: 6147102
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant neuroleptic syndrome due to haloperidol. (A case report).
    Samar RK; Kaushik SK; Garg AR
    J Postgrad Med; 1983 Jan; 29(1):56-8. PubMed ID: 6864584
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.